NASDAQ$OPCH

Option Care Health, Inc · Q4 2022 earnings

Q4 2022 earnings · · Investor relations

Briefing

Option Care Health reported solid financial results driven by their technology-enabled national network.

Option Care Health reported net revenue of $1,027.2 million for Q4 2022, up 10.8% compared to the same period in 2021. Net income for the quarter was $47.5 million, or $0.26 earnings per share. Adjusted EBITDA was $94.3 million, an increase of 8.7% compared to Q4 2021.

  • Net revenue increased by 10.8% to $1,027.2 million compared to Q4 2021.
  • Gross profit increased by 8.9% to $231.1 million, representing 22.5% of revenue.
  • Net income was $47.5 million, or $0.26 earnings per share.
  • Adjusted EBITDA grew by 8.7% to $94.3 million compared to Q4 2021.

Headline financials

Total Revenue

$1.03B

Previous: $927M+10.8%
EPS (adj)

$0.26

Previous: $0.25+4.0%
Adjusted EBITDA

$94.3M

Previous: $86.8M+8.6%
Capital Expenditures

$18.2M

Previous: $13.9M+31.4%
Free Cash Flow

$25.2M

Previous: $51.4M-51.0%
Net Income

$47.5M

Previous: $75.5M-37.0%
Operating Income

$68.2M

Previous: $60.8M+12.2%
Gross Profit

$231M

Previous: $212M+8.9%
Cash & Equivalents

$294M

Previous: $119M+146.3%
Total Assets

$3.11B

Previous: $2.79B+11.5%
Stock-Based Comp

$4.2M

Previous: $3.33M+26.2%

Revenue & EPS history

Option Care Health · Revenue · Quarterly

$1.03B

Q4 2022+10.8%vs Q4 2021
Beat estimate in 11 of 15 quarters(73%)
ActualEstimate

Forward guidance

For the full year 2023, Option Care Health expects to deliver net revenue of $4.15 billion to $4.375 billion, adjusted EBITDA of $370 million to $390 million, and cash flow from operations of at least $240 million.

Tailwinds

  • Net revenue of $4.15 billion to $4.375 billion
  • Adjusted EBITDA of $370 million to $390 million
  • Cash flow from operations of at least $240 million
  • Effective tax rate of 27% - 29%
  • Net interest expense of approximately $61.0 million to $65.0 million

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2022

Historical avgQ4 2022

-1.9%

Avg return

Earnings day

-4.2%

Avg return

5 days after

-1.9%

Avg return

30 days after

50%

36 / 72 earnings

Positive

+27.4%

Q3 2015

Best reaction

-53.6%

Q3 2016

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-24.3%-20.7%-22.4%
Q4 2025-7.3%-10.1%-23.1%
Q3 2025-8.7%-5.7%+8.5%
Q1 2025-6.9%-0.1%-2.2%
Q4 2024+1.6%+4.1%+6.4%
Q3 2024-24.5%-26.3%-22.0%
Q2 2024-1.9%-5.3%+2.1%
Q1 2024-1.6%-2.6%-6.0%
Q4 2023-3.4%-1.8%-2.0%
Q3 2023-15.6%-18.4%-8.1%
Q2 2023+5.3%+4.0%+7.9%
Q1 2023-14.7%-12.6%-11.4%
Q4 2022+7.1%+6.3%+9.4%
Q3 2022-10.9%-13.3%-17.6%
Q2 2022+5.0%+4.8%-2.2%
Q1 2022+10.3%+7.4%+14.2%
Q4 2021+8.6%+10.8%+20.9%
Q3 2021-0.0%-2.1%-12.1%
Q2 2021-0.1%+8.3%+35.1%
Q1 2021-4.7%-8.8%+2.3%
Q4 2020+2.2%+1.9%-3.7%
Q3 2020+11.4%+11.7%+14.1%
Q2 2020+3.6%+1.7%-2.8%
Q1 2020+8.8%+6.6%+32.7%
Q4 2019-12.8%-16.1%-48.4%
Q3 2019-2.4%-5.9%-16.3%
Q2 2019-1.4%-5.2%+21.5%
Q1 2019-2.5%-1.5%-4.0%
Q4 2018-33.0%-38.7%-50.4%
Q3 2018+16.0%+12.8%+34.2%
Q2 2018-1.5%+2.5%+4.4%
Q1 2018-6.1%-0.4%+6.9%
Q4 2017+3.3%+0.0%+9.8%
Q3 2017-13.8%-18.8%+5.8%
Q2 2017+8.6%+21.8%+6.8%
Q1 2017+3.6%+1.8%+24.2%
Q4 2016-12.3%-10.6%-33.9%
Q3 2016-53.6%-47.9%-56.3%
Q2 2016+3.0%+2.6%+2.3%
Q1 2016+3.1%
Q4 2015+7.1%
Q3 2015+27.4%
Q2 2015-22.8%
Q1 2015-10.0%
Q4 2014-11.3%
Q3 2014+1.3%
Q2 2014-4.4%
Q1 2014+2.1%
Q4 2013+6.3%
Q2 1997+9.0%
Q3 2013-4.6%
Q2 2013-17.2%
Q1 2013-0.1%
Q4 2012-1.5%
Q3 2012+3.7%
Q2 2012+11.0%
Q1 2012+3.2%
Q4 2011-1.5%
Q3 2011-11.2%
Q2 2011+1.5%
Q4 2010+1.5%
Q1 2011-1.4%
Q3 2010+8.1%
Q2 2010-3.0%
Q1 2009+0.9%
Q1 2010+3.4%
Q2 2009+2.6%
Q4 2007+2.6%
Q4 2009+2.6%
Q3 2009+5.6%
Q3 2008+5.6%
Q4 2008+5.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro